empty
 
 
bg
Търсене
Подкрепа
Незабавно отваряне на акаунт
Платформа за търговия
Депозит / Теглене
Търсене
За начинаещи За търговци За партньори Вземете си почивка За ИнстаФорекс
bg
#DVAX Обратно към списъка с инструменти #ELAN

Конвентор на валута

DexCom Inc.
65.6 USD
09 Dec 2025 22:59
Ценова промяна (% chg)
$-0.01
(-0.02%)
Предишно затваряне
Предишно затваряне

Затваряща цена, предишен ден.
$64.9
Отваряне
Отваряне

Цена на отваряне.
$64.35
Дневен връх
Дневен връх

Най-високата цена през последния търговски ден.
$65.91
Дневно дъно
Дневно дъно

Най-ниската цена през последния ден за търговия
$63.73
52-седмичен връх
52-седмичен връх

Връх на ценовия диапазон за последните 52 седмици
$65.91
52-седмично дъно
52-седмично дъно

Дъно на ценовия диапазон за последните 52 седмици
$61.61
Свалете архива
Buy
65.6
Sell
65.6
Open the chart in full screen view
Buy
65.6
Sell
65.6
Свалете архива
Open the chart in full screen view

About DexCom Inc.

DexCom Inc. is a US-based medtech company established in 1999. The company is focused on developing and producing medical equipment. 

Its major product is a continuous glucose monitoring (CGM) system for people suffering from diabetes. The CGM system enables real-time continuous blood monitoring which is then transferred to a user's smart device.;

DexCom Inc. sells its products directly or through distributors in the United States and internationally. 

The company's market capitalization is currently estimated at $39.79 billion. Over the past year, it posted revenue of $2.448 billion and a net profit of $154.7 million. 

DexCom Inc. shares and what affects their value;

The shares of DexCom Inc. have been trading on the NASDAQ stock exchange under the ticker “DXCM” since 2005. The initial price of one share was $12.

At the moment, the stock is trading in the range between $99 and $103. Over the past year, the stock price fluctuated between a low of $66 and a high of $165.

What to consider when trading the asset:

  • The company has a good reputation and a brand that is recognized across the world;
  • Strong international presence;
  • The company develops its own mobile apps and prioritizes innovative technologies;
  • DexCom Inc. had no competitors for quite a long time. Today, however, other medical companies have presented a similar device and may easily claim its share in the market;
  • Strong competition forces the company to cut production costs and fight for customers’ attention by constantly improving its products;
  • The ability to collect data from patients using the company’s devices enables DexCom Inc. to develop personalized treatment plans.

Не можете да говорите точно сега?
Задайте въпроса си в чат.